(2) HORMONAL ORAL CHEMOTHERAPY BENEFIT: Aflac will
pay $250 per Calendar Month for up to 24 months during
which a Covered Person is prescribed, receives, and incurs
a charge for Hormonal Oral Chemotherapy for the treatment
of Cancer or an Associated Cancerous Condition. After 24
months of paid benefits of Hormonal Oral Chemotherapy for
a Covered Person, Aflac will pay $75 per Calendar Month
during which a Covered Person is prescribed, receives, and
incurs a charge for Hormonal Oral Chemotherapy for the
treatment of Cancer or an Associated Cancerous Condition.
Examples of Hormonal Oral Chemotherapy treatments
include but are not limited to Nolvadex, Arimidex, Femara,
and Lupron and their generic versions, such as tamoxifen.
(3) TOPICAL CHEMOTHERAPY BENEFIT: Aflac will pay $150
per Calendar Month during which a Covered Person is
prescribed, receives, and incurs a charge for a Topical
Chemotherapy for the treatment of Cancer or an Associated
Cancerous Condition.
Oral/Topical Chemotherapy benefits are limited to the
Calendar Month in which the charge for the medication(s)
or treatment is incurred. If the prescription is for more
than one month, the benefit is limited to the Calendar
Month in which the charge is incurred. Total benefits
are payable for up to three different Oral/Topical
Chemotherapy medicines per Calendar Month, up to a
maximum of $750 per Calendar Month. Refills of the same
prescription within the same Calendar Month are not
considered a different Chemotherapy medicine. No lifetime
maximum.
c. RADIATION THERAPY BENEFIT: Aflac will pay $350 once
per Calendar Week during which a Covered Person receives
and incurs a charge for Radiation Therapy for the treatment
of Cancer or an Associated Cancerous Condition. This benefit
will not be paid for each week a radium implant or radioisotope
remains in the body. This benefit is limited to the Calendar
Week in which the charge for the therapy is incurred. No
lifetime maximum.
d. EXPERIMENTAL TREATMENT BENEFIT: Aflac will pay $350
once per Calendar Week during which a Covered Person
receives and incurs a charge for Physician-prescribed
experimental Cancer chemotherapy medications. Aflac will
pay $100 once per Calendar Week during which a Covered
Person receives Physician-prescribed experimental Cancer
chemotherapy medications as part of a clinical trial that does
not charge patients for such medications.
Chemotherapy medications must be approved by the NCI as a
viable experimental treatment for Cancer. This benefit does not
pay for laboratory tests, diagnostic X-rays, immunoglobulins,
Immunotherapy, colony-stimulating factors, and therapeutic
devices or other procedures related to these experimental
treatments. Benefits will not be paid for each week of
continuous infusion of medications dispensed by a pump,
implant, or patch. This benefit is limited to the Calendar Week in
which the charge for the chemotherapy medications is incurred.
No lifetime maximum.
Benefits will not be paid under the Experimental Treatment
Benefit for any medications paid under the Immunotherapy
Benefit.
2. INDIRECT/ADDITIONAL THERAPY BENEFITS: The following
benefits are not payable based on the number, duration, or
frequency of Immunotherapy or antinausea drugs received
by the Covered Person.
a. IMMUNOTHERAPY BENEFIT: Aflac will pay $350 per Calendar
Month during which a Covered Person receives and incurs
a charge for Physician-prescribed Immunotherapy as part
of a treatment regimen for Internal Cancer or an Associated
Cancerous Condition. This benefit is payable only once per
Calendar Month. It is limited to the Calendar Month in which
the charge for Immunotherapy is incurred. Lifetime maximum
of $1,750 per Covered Person.
Benefits will not be paid under the Immunotherapy
Benefit for any medications paid under the Experimental
Treatment Benefit.
b. ANTINAUSEA BENEFIT: Aflac will pay $100 per Calendar Month
during which a Covered Person receives and incurs a charge
for antinausea drugs that are prescribed in conjunction with
Radiation Therapy Benefits, Injected Chemotherapy Benefits,
Oral/Topical Chemotherapy Benefits, or Experimental Treatment
Benefits. This benefit is payable only once per Calendar Month
and is limited to the Calendar Month in which the charge for
antinausea drugs is incurred. No lifetime maximum.
c. STEM CELL TRANSPLANTATION BENEFIT: Aflac will pay
$7,000 when a Covered Person receives and incurs a charge
for a peripheral Stem Cell Transplantation for the treatment of
Internal Cancer or an Associated Cancerous Condition. This
benefit is payable once per Covered Person. Lifetime maximum
of $7,000 per Covered Person.
d. BONE MARROW TRANSPLANTATION BENEFIT: (1) Aflac will
pay $7,000 when a Covered Person receives and incurs a
charge for a Bone Marrow Transplantation for the treatment of
Internal Cancer or an Associated Cancerous Condition. (2) Aflac
will pay the Covered Person’s bone marrow donor an indemnity
of $750 for his or her expenses incurred as a result of the
transplantation procedure. Lifetime maximum of $7,000 per
Covered Person.
e. BLOOD AND PLASMA BENEFIT: Aflac will pay $100 times
the number of days paid under the Hospital Confinement
Benefit when a Covered Person receives and incurs a charge
for blood and/or plasma transfusions during a covered
7